Abstract:Approximately 50% of deaths in ESRD patients are attributed to cardiovascular (CV) related pathology. Only 2.5% of ESRD patients receive a kidney transplant, while the rest rely on dialysis for survival. Peritoneal dialysis (PD) therapy has been increasingly utilized in recent years, yet there is a paucity in data characterizing the effects of PD on CV function. The goal of this study was to assess molecular changes in response to PD to understand how PD could impact prevalence of CV mortality in ESRD. We hypothesized that PD would not improve CKD‐related CV pathology despite providing support during renal insufficiency. To determine how PD effects renal and left ventricle (LV) structural and functional, organ morphology, and gene expression, 10‐week‐old male rats underwent 5/6Nx or Sham operation. Peritoneal catheters were implanted 6 weeks post‐surgery. PD was initiated 3 days later in half of the 5/6Nx and sham animals (15ml [Baxter PD‐2 2.5%] 1‐hour dwell 3x/day x 8 days) for n=6‐7 per surgical and treatment group. Echocardiography, blood collection, and urine collection were performed at baseline, 6, and 7‐weeks post‐surgery. Acute carotid blood pressure was measured week 7. Results were analyzed by two‐way ANOVA and significance determined at p<0.05. Sequencing of RNA isolated from kidney and LV was performed (n=6 per surgical group and treatment). Statistical analysis of transcriptomic results compared transcript levels from rats that received PD and those that did not. Differential gene expression was determined using the R package DESeq2. The Benjamini‐Hochberg method was used to control FDR in differential expression analysis to provide an adjusted p‐value. Transcripts with an adjusted p‐value (q‐value) <0.05 were identified as differentially expressed genes (DEGs) for subsequent pathway analysis, regardless of fold change. The list of DEGs was entered into Ingenuity Pathway Analysis (IPA) for subsequent analysis. PD had no effect on LV parameters or blood pressure in Sham or 5/6Nx rats. Blood urea nitrogen, serum creatine, SDMA and cholesterol were significantly higher in 5/6Nx rats compared to sham rats and PD attenuated that increase. Serum triglycerides were also increased in 5/6Nx compared to sham, but augmented further with PD. RNA sequencing yielded >50 million reads (100 bp in length) per sample. The mapping rate for this dataset was >96% for all samples. Transcripts were considered differentially expressed with an adjusted p‐value <0.05. This identified numerous DEGs resulting from PD in sham LV, 5/6Nx LV, sham kidney and 5/6Nx kidney tissues (853, 162, 637, and 33 DEGs, respectively). IPA analysis predicted gene changes consistent with increased inflammatory responses in both the LV and kidney tissues from sham controls receiving PD, suggesting that dialysis alone may induce multi‐organ inflammatory signaling. The DEG pattern of enrichment in LV tissue from sham rats receiving PD indicated that the “Phagosome Formation“ pathway was activated, while the “EIF2 Signaling” pathway was highly enriched and activated in kidney tissue from sham rats receiving PD. In summary, our transcriptomic analysis identified a pro‐immune/inflammatory state resulting from PD alone, even in sham‐operated controls with normal renal function. The transcriptomic data align with our physiological measurements indicating PD did not diminish or improve cardiac function in sham or 5/6Nx rats, rather PD may augment inflammatory signaling to increase risk factors for CVD and cardiac mortality.

The use of peritoneal dialysis in the treatment of patients with cardio-renal syndrome Ⅱ

Comparative Analysis of Efficacy and Prognosis of Hemodialysis and Peritoneal Dialysis for End-Stage Renal Disease: A Meta-analysis.

Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure Due to Chronic Cardiorenal Syndrome.

Progress of research on the role of peritoneal dialysis in treatment of cardiorenal syndrome type Ⅰand Ⅱ

Cardiorenal Syndrome in Incident Peritoneal Dialysis Patients: What is Its Effect on Patients' Outcomes?

Comparison of the effect of hemodialysis and peritoneal dialysis in the treatment of end-stage renal disease

Peritoneal Dialysis in Patients with Primary Cardiac Failure Complicated by Renal Failure

Effects of Residential Renal Function on Cardiovascular System in Patients with Peritoneal Dialysis

Two Patients with Non-uremia Diabetic Nephropathy and Peritoneal Dialysis and Literatre Reviews

Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis

Peritoneal Dialysis for Children with Acute Renal Failure Following Cardiac Surgery of Congenital Heart Disease

Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review.

Transcriptomic Profiling Reveals Left Ventricle and Kidney Pathology Resulting from Peritoneal Dialysis

Effect of peritoneal dialysis and hemodialysis dialysis on myocardial injury

[Efficacy of sacubitril/valsartan in peritoneal dialysis patients with HFpEF and its effect on residual renal function].

Effect of peritoneal dialysis on inflammatory factors,nutritional index and renal function in patients with chronic renal failure

Effects of Different Dialysis Methods on Calcium and Phosphorus Metabolism and Inflammatory Factor Levels in Patients with End-Stage Renal Disease

#2920 Peritoneal dialysis for volume overload in heart failure: a single-center experience

Hemodialysis Versus Peritoneal Dialysis: an Observational Study in Two International Centers

Analysis of Outcome and Factors Correlated with Maintenance Peritoneal Dialysis

The Effection of Two Types of Dialysis on Blood Pressure and Vasoactive Substance in Uremic Patients with Refractory Hypertension